R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
R&D
On US drug shortages and compounding pharmacies, with Shawn ...
Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.
News
FDA could hike user fees for ex-US drug programmes
FDA mulls reduced fees for programmes with US-based phase 1 trials, and higher fees for those tested overseas, to incentivise US R&D.
R&D
Seamless scale-up: Integrated manufacturing becomes the biop...
Today, the demand for speed, quality, and scalability is pushing the industry towards a different model: integrated manufacturing.
News
Bayer takes Alport syndrome drug into phase 2
Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying therapy for Alport syndrome.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
